Cooper Return on Tangible Equity 2010-2024 | COO

Current and historical return on tangible equity values for Cooper (COO) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Cooper Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-01-31 $0.29B $2.07B 14.08%
2023-10-31 $0.30B $2.22B 14.76%
2023-07-31 $0.28B $2.08B 14.80%
2023-04-30 $0.29B $1.90B 16.80%
2023-01-31 $0.38B $1.80B 23.62%
2022-10-31 $0.39B $1.68B 26.55%
2022-07-31 $0.43B $1.50B 23.78%
2022-04-30 $0.95B $1.39B 43.97%
2022-01-31 $0.94B $1.25B 39.87%
2021-10-31 $2.95B $3.10B 114.93%
2021-07-31 $2.92B $2.89B 161.06%
2021-04-30 $2.36B $2.18B 216.35%
2021-01-31 $2.25B $2.08B 436.49%
2020-10-31 $0.24B $0.09B -901.89%
2020-07-31 $0.28B $0.00B -278.30%
2020-04-30 $0.34B $-0.11B -221.94%
2020-01-31 $0.45B $-0.09B -206.36%
2019-10-31 $0.47B $-0.21B -140.26%
2019-07-31 $0.45B $-0.22B -103.18%
2019-04-30 $0.43B $-0.37B -75.31%
2019-01-31 $0.37B $-0.54B -52.79%
2018-10-31 $0.14B $-0.61B -17.94%
2018-07-31 $0.13B $-0.75B -23.28%
2018-04-30 $0.13B $-0.88B -44.67%
2018-01-31 $0.18B $-0.89B -479.45%
2017-10-31 $0.37B $0.32B 191.55%
2017-07-31 $0.35B $0.27B 249.37%
2017-04-30 $0.33B $0.15B 390.53%
2017-01-31 $0.30B $0.04B 458.24%
2016-10-31 $0.27B $0.09B 416.73%
2016-07-31 $0.25B $0.06B 418.41%
2016-04-30 $0.21B $0.08B 289.51%
2016-01-31 $0.19B $0.04B 326.05%
2015-10-31 $0.20B $0.07B 600.00%
2015-07-31 $0.20B $0.10B -4950.00%
2015-04-30 $0.24B $0.03B 97.28%
2015-01-31 $0.26B $-0.06B 53.21%
2014-10-31 $0.27B $-0.09B 37.49%
2014-07-31 $0.30B $1.11B 31.13%
2014-04-30 $0.30B $0.98B 33.46%
2014-01-31 $0.29B $0.88B 35.39%
2013-10-31 $0.30B $0.84B 38.23%
2013-07-31 $0.31B $0.86B 43.07%
2013-04-30 $0.29B $0.74B 45.37%
2013-01-31 $0.27B $0.66B 43.95%
2012-10-31 $0.25B $0.63B 42.75%
2012-07-31 $0.23B $0.52B 41.88%
2012-04-30 $0.21B $0.64B 38.17%
2012-01-31 $0.19B $0.54B 38.76%
2011-10-31 $0.18B $0.53B 39.95%
2011-07-31 $0.17B $0.49B 43.97%
2011-04-30 $0.16B $0.40B 52.38%
2011-01-31 $0.13B $0.32B 52.40%
2010-10-31 $0.11B $0.29B 52.15%
2010-07-31 $0.09B $0.22B 51.02%
2010-04-30 $0.08B $0.17B 46.63%
2010-01-31 $0.10B $0.18B 71.19%
2009-10-31 $0.10B $0.17B 108.31%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $17.972B $3.593B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $68.967B 18.46
Becton Dickinson (BDX) United States $67.638B 19.64
West Pharmaceutical Services (WST) United States $27.235B 46.04
Cardinal Health (CAH) United States $26.315B 15.82
Align Technology (ALGN) United States $22.499B 45.37
Labcorp (LH) United States $16.950B 14.47
Henry Schein (HSIC) United States $9.104B 15.75
DENTSPLY SIRONA (XRAY) United States $6.325B 16.67
Merit Medical Systems (MMSI) United States $4.182B 23.93
Patterson (PDCO) United States $2.331B 11.17
STAAR Surgical (STAA) United States $2.267B 71.37
CONMED (CNMD) United States $2.237B 21.06
Atrion (ATRI) United States $0.708B 36.48
Lifevantage (LFVN) United States $0.086B 13.96
Pro-Dex (PDEX) United States $0.067B 25.33
Biolase (BIOL) United States $0.005B 0.00